Cigna faces turbulence as proposed Medicaid cuts cast shadows on its financial forecast, despite strong first-quarter ...

CVS is trading at a trailing 12-month price-to-earnings, a commonly used multiple for valuing healthcare stocks, of 9.65X, ...

Cigna’s latest SWOT analysis shows a company flexing its market muscles despite tricky healthcare headwinds. Cigna’s strong ...

Boards have increasingly benchmarked against peers as companies release more detailed pay data, per the research.

The subdued stock price reaction suggests that The Cigna Group's (NYSE:CI) strong earnings didn't offer any surprises. Our analysis suggests that investors might be missing some promising details.

On Wednesday, Bernstein analysts increased their price target for Cigna Corporation (NYSE: CI) shares from $323.00 to $373.00, while maintaining a Market Perform rating.The healthcare giant, with a ...

Jefferies lifts Cigna stock price target to $397, maintains buy rating ...

The stock’s performance remains strong within its 52-week range of $262.03 to $370.83, indicating positive market sentiment. Based on InvestingPro’s Fair Value analysis, Cigna appears undervalued, ...

The stock’s performance remains strong within its 52-week range of $262.03 to $370.83, indicating positive market sentiment. Based on InvestingPro’s Fair Value analysis, Cigna appears ...

Cigna Corporation (NYSE:CI), a global health service organization with a market capitalization of $87 billion, has been navigating a complex landscape of market shifts, regulatory changes, and ...